Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
A snapshot of the year-to-date total market return for 2024, outlining performance drivers and practical implications for investors.
28,420 articlesA niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
When a memory-stock rally hits the headlines, you want the real story behind the move. This guide explains why sandis...
A major fund manager disclosed a sizable exit from a tactical commodity ETF, signaling a shift in market stance. This...
When a leading fund sells a sizable stake in a cyclical manufacturer after a rough quarter, investors want clarity. T...
A Duke University professor warns that Bitcoin's risk profile could shift as derivatives liquidity makes a 51% attack...
Micron stock soaring today is more than a quick move. This guide explains the drivers, how to read the memory market ...
Bitcoin slid below 78,000 over the weekend, prompting a surge in downside hedging as traders priced in volatility and...
If Vertex pursues Crinetics, what would it mean for the stock? This article breaks down potential value, risks, and t...
CrowdStrike has shown momentum, but the stock carries risk. Here’s why I’m skeptical and how investors can approach c...
Pinterest stock is slipping mid-session, dropping around 6% to near $18.75 as peers like Meta and Snap show lighter d...
Imagine a Corcept director with 1.5 million shares weathering a 50% stock crash and a strong rebound. This article br...
SanDisk shares jumped on fresh momentum as data-center demand and NAND constraints propel a potential multi-year rall...